rs373267047
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2
The ENST00000358385.12(ATL1):c.1078G>A(p.Val360Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V360G) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000358385.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATL1 | NM_015915.5 | c.1078G>A | p.Val360Met | missense_variant | 11/14 | ENST00000358385.12 | NP_056999.2 | |
ATL1 | NM_001127713.1 | c.1078G>A | p.Val360Met | missense_variant | 12/14 | NP_001121185.1 | ||
ATL1 | NM_181598.4 | c.1078G>A | p.Val360Met | missense_variant | 11/13 | NP_853629.2 | ||
ATL1 | XM_047431430.1 | c.1078G>A | p.Val360Met | missense_variant | 12/15 | XP_047287386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATL1 | ENST00000358385.12 | c.1078G>A | p.Val360Met | missense_variant | 11/14 | 1 | NM_015915.5 | ENSP00000351155 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251010Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135648
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461606Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 727076
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74366
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 09, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 30, 2021 | - - |
Hereditary spastic paraplegia 3A Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 360 of the ATL1 protein (p.Val360Met). This variant is present in population databases (rs373267047, gnomAD 0.008%). This missense change has been observed in individuals with clinical features of autosomal dominant ATL1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 390443). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATL1 protein function with a negative predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2021 | The p.V360M variant (also known as c.1078G>A), located in coding exon 11 of the ATL1 gene, results from a G to A substitution at nucleotide position 1078. The valine at codon 360 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, this variant is unlikely to be causative of autosomal dominant spastic paraplegia 3A (SPG3A) or hereditary sensory neuropathy type ID (HSN1D); however, its contribution to the development of autosomal recessive spastic paraplegia 3A is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at